These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 17107274)

  • 1. Can statins put the brakes on Alzheimer's disease?
    Whitfield JF
    Expert Opin Investig Drugs; 2006 Dec; 15(12):1479-85. PubMed ID: 17107274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cholesterol and Alzheimer's disease].
    Kálmán J; Janka Z
    Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of HMG-CoA reductase inhibitors on beta-amyloid peptide levels: implications for Alzheimer's disease.
    Höglund K; Blennow K
    CNS Drugs; 2007; 21(6):449-62. PubMed ID: 17521225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease-modifying therapies in Alzheimer's disease: how far have we come?
    Hüll M; Berger M; Heneka M
    Drugs; 2006; 66(16):2075-93. PubMed ID: 17112302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol and statins in Alzheimer's disease: current controversies.
    Fonseca AC; Resende R; Oliveira CR; Pereira CM
    Exp Neurol; 2010 Jun; 223(2):282-93. PubMed ID: 19782682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol and Alzheimer's disease.
    Wolozin B
    Biochem Soc Trans; 2002 Aug; 30(4):525-9. PubMed ID: 12196129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol and Alzheimer's disease: is there a link?
    Simons M; Keller P; Dichgans J; Schulz JB
    Neurology; 2001 Sep; 57(6):1089-93. PubMed ID: 11571339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol in Alzheimer's disease and other amyloidogenic disorders.
    Harris JR; Milton NG
    Subcell Biochem; 2010; 51():47-75. PubMed ID: 20213540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins cause intracellular accumulation of amyloid precursor protein, beta-secretase-cleaved fragments, and amyloid beta-peptide via an isoprenoid-dependent mechanism.
    Cole SL; Grudzien A; Manhart IO; Kelly BL; Oakley H; Vassar R
    J Biol Chem; 2005 May; 280(19):18755-70. PubMed ID: 15718241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of amyloid precursor protein, amyloid-beta and gamma-secretase in cholesterol maintenance.
    Hartmann T
    Neurodegener Dis; 2006; 3(4-5):305-11. PubMed ID: 17047372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-assessing the relationship between cholesterol, statins and Alzheimer's disease.
    Wolozin B; Manger J; Bryant R; Cordy J; Green RC; McKee A
    Acta Neurol Scand Suppl; 2006; 185():63-70. PubMed ID: 16866913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A lipid boundary separates APP and secretases and limits amyloid beta-peptide generation.
    Kaether C; Haass C
    J Cell Biol; 2004 Dec; 167(5):809-12. PubMed ID: 15583026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The conflicting role of brain cholesterol in Alzheimer's disease: lessons from the brain plasminogen system.
    Ledesma MD; Dotti CG
    Biochem Soc Symp; 2005; (72):129-38. PubMed ID: 15649137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anomalies occurring in lipid profiles and protein distribution in frontal cortex lipid rafts in dementia with Lewy bodies disclose neurochemical traits partially shared by Alzheimer's and Parkinson's diseases.
    Marin R; Fabelo N; Martín V; Garcia-Esparcia P; Ferrer I; Quinto-Alemany D; Díaz M
    Neurobiol Aging; 2017 Jan; 49():52-59. PubMed ID: 27768960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The involvement of lipid rafts in Alzheimer's disease.
    Cordy JM; Hooper NM; Turner AJ
    Mol Membr Biol; 2006; 23(1):111-22. PubMed ID: 16611586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the lipidation of beta-secretase by statins.
    Parsons RB; Farrant JK; Price GC; Subramaniam D; Austen BM
    Biochem Soc Trans; 2007 Jun; 35(Pt 3):577-82. PubMed ID: 17511656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of statins on beta-amyloid metabolism in humans: potential importance for the development of senile plaques in Alzheimer's disease.
    Höglund K; Wallin A; Blennow K
    Acta Neurol Scand Suppl; 2006; 185():87-92. PubMed ID: 16866916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LRRTM3 promotes processing of amyloid-precursor protein by BACE1 and is a positional candidate gene for late-onset Alzheimer's disease.
    Majercak J; Ray WJ; Espeseth A; Simon A; Shi XP; Wolffe C; Getty K; Marine S; Stec E; Ferrer M; Strulovici B; Bartz S; Gates A; Xu M; Huang Q; Ma L; Shughrue P; Burchard J; Colussi D; Pietrak B; Kahana J; Beher D; Rosahl T; Shearman M; Hazuda D; Sachs AB; Koblan KS; Seabrook GR; Stone DJ
    Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17967-72. PubMed ID: 17098871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.